WCLC 2025 - Posters & ePosters-P2.02.11 SRC Activation Drives Acquired Pemetrexed Resistance in Non-Small Cell Lung Cancer and Is Targetable by Dasatinib

P2.02.11 SRC Activation Drives Acquired Pemetrexed Resistance in Non-Small Cell Lung Cancer and Is Targetable by Dasatinib

Asset Subtitle

Jeongmin Seo

Meta Tag

Speaker Jeongmin Seo

Topic Tumor Biology – Preclinical Biology